Food and Drug Regulations, C.R.C., c. 870

Section C.07.003

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.07.003 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

An application by a manufacturer for authorization to sell a drug under this Division shall be submitted to the Minister and shall contain the following information and documents: (a) a statement that the manufacturer intends to file an application with the Commissioner of Patents under section 21.04 of the Patent Act; (b) in respect of a new drug, the submission number and date of filing of the new drug submission or abbreviated new drug submission filed under section C.08.002 or C.08.002.1, respectively, and of any supplement filed under section C.08.003 in respect of the drug; (c) in respect of a drug that is not a new drug, (i) the application number and date of filing of the application that has been filed under section C.01.014.1 in respect of the drug, or (ii) the drug identification number, if one has been assigned in respect of the drug pursuant to section C.01.014.2; (d) for a drug in a solid dosage form, the manner in which the drug is marked in accordance with paragraph C.07.008(a) and evidence that such manner does not alter the safety and efficacy of the drug; (e) for a drug in a dosage form that is not solid, the manner in which the immediate container is marked in accordance with paragraph C.07.008(a); and (f) a sample of the label for the drug that includes the information required by paragraph C.07.008(c).
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.